학술논문
900 - Enzalutamide in men with chemotherapy-naïve metastatic castration-resistant prostate cancer (mCRPC): Long-term overall survival and safety analyses of the phase 3 PREVAIL study
Document Type
Abstract
Author
Source
In European Urology Supplements March 2019 18(1):e1217-e1218
Subject
Language
ISSN
1569-9056